Literature DB >> 2578915

Low-molecular-weight iron complexes and oxygen radical reactions in idiopathic haemochromatosis.

J M Gutteridge, D A Rowley, E Griffiths, B Halliwell.   

Abstract

The sera of patients with idiopathic haemochromatosis and iron-overload have been found to contain low-molecular-weight iron complexes detectable in the 'bleomycin assay'. These complexes stimulate both the peroxidation of membrane lipids and the formation of the highly reactive and damaging hydroxyl radical. The iron chelator desferrioxamine interferes with these reactions. We suggest that oxygen radical reactions stimulated by iron salts are important in the pathology of idiopathic haemochromatosis.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2578915     DOI: 10.1042/cs0680463

Source DB:  PubMed          Journal:  Clin Sci (Lond)        ISSN: 0143-5221            Impact factor:   6.124


  43 in total

1.  Unexpected effects of albumin on apoptosis induction by deferoxamine in vitro.

Authors:  J Kovár; J D Kemp
Journal:  In Vitro Cell Dev Biol Anim       Date:  2000-03       Impact factor: 2.416

2.  Genetic and physiologic characterization of ferric/cupric reductase constitutive mutants of Cryptococcus neoformans.

Authors:  K J Nyhus; E S Jacobson
Journal:  Infect Immun       Date:  1999-05       Impact factor: 3.441

Review 3.  Immune cell functions in iron overload.

Authors:  M de Sousa
Journal:  Clin Exp Immunol       Date:  1989-01       Impact factor: 4.330

4.  A case of transfusion independence in a patient with myelodysplastic syndrome using deferasirox, sustained for two years after stopping therapy.

Authors:  D Sanford; C C Hsia
Journal:  Curr Oncol       Date:  2015-04       Impact factor: 3.677

5.  Short-lasting accumulation in osteoid bone seams of radioactive iron injected as citrate into mice.

Authors:  H Huser; L Gerber; P Eichenberger; E Waelti; H Cottier
Journal:  Am J Pathol       Date:  1988-05       Impact factor: 4.307

6.  Oxidative stress and labile plasmatic iron in anemic patients following blood therapy.

Authors:  Marília Sabo Fernandes; Tatiana Tamborena Rissi; Luisa Zuravski; Juliana Mezzomo; Carmen Regla Vargas; Vanderlei Folmer; Félix Alexandre Antunes Soares; Vanusa Manfredini; Mushtaq Ahmed; Robson Luiz Puntel
Journal:  World J Exp Med       Date:  2014-08-20

7.  Involvement of polyamines in iron(III) transport in human intestinal Caco-2 cell lines.

Authors:  Gérard Lescoat; Lucie Gouffier; Isabelle Cannie; Olive Lowe; Isabelle Morel; Sylvie Lepage; Martine Ropert; Olivier Loréal; Pierre Brissot; François Gaboriau
Journal:  Mol Cell Biochem       Date:  2013-03-14       Impact factor: 3.396

Review 8.  Hereditary hemochromatosis and diabetes mellitus: implications for clinical practice.

Authors:  Kristina M Utzschneider; Kris V Kowdley
Journal:  Nat Rev Endocrinol       Date:  2010-01       Impact factor: 43.330

9.  HFE Gene Variants' Impact on Anthracycline-Based Chemotherapy-Induced Subclinical Cardiotoxicity.

Authors:  Domas Vaitiekus; Gintare Muckiene; Audrone Vaitiekiene; Liveta Sereikaite; Ruta Inciuraite; Ruta Insodaite; Daiva Cepuliene; Juozas Kupcinskas; Rasa Ugenskiene; Renaldas Jurkevicius; Elona Juozaityte
Journal:  Cardiovasc Toxicol       Date:  2020-08-03       Impact factor: 3.231

10.  Monocyte-macrophage ferric reductase activity is inhibited by iron and stimulated by cellular differentiation.

Authors:  J Partridge; D F Wallace; K B Raja; J S Dooley; A P Walker
Journal:  Biochem J       Date:  1998-12-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.